| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $228.9M | +729.2% |
| R&D Expense | $9.5M | -9.2% |
| SG&A Expense | $21.8M | -3.8% |
| Operating Income | $3.2M | +170.1% |
| Pre-tax Income | $8.4M | +573.7% |
| Income Tax | $574K | +510.6% |
| Net Income | $7.8M | +578.8% |
| EPS (Basic) | $0.05 | +400.0% |
| EPS (Diluted) | $0.04 | +300.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.4M | -51.3% |
| Accounts Receivable | $16.1M | +66.6% |
| Current Assets | $111.1M | -14.7% |
| Total Assets | $134.9M | -2.8% |
| Current Liabilities | $17.4M | -8.6% |
| Total Liabilities | $17.8M | -16.1% |
| Stockholders' Equity | $117.0M | -0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.5M | -27.1% |
| Investing Cash Flow | -$28.9M | +38.2% |
| Financing Cash Flow | -$19.0M | -55.9% |